Literature DB >> 30506129

Promising practices for the prevention of liver cancer: a review of the literature and cancer plan activities in the National Comprehensive Cancer Control Program.

Behnoosh Momin1, Alexander J Millman2, Danielle Beauchesne Nielsen3, Michelle Revels3, C Brooke Steele4.   

Abstract

INTRODUCTION: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are risk factors for hepatocellular carcinoma, a type of primary liver cancer, and are most prevalent in people born 1945-1965. Relatively little information is available for liver cancer prevention, compared to other cancers. In this review, we provide a summary of current promising public health practices for liver cancer prevention from the literature, as well as liver cancer-related initiatives in the National Comprehensive Cancer Control Program (NCCCP).
METHODS: Two types of source materials were analyzed for this review: published literature (2005-present), and current cancer plans from the NCCCP (2005-2022). A search strategy was developed to include a review of several scientific databases. Of the 73 articles identified as potentially eligible, 20 articles were eligible for inclusion in the review. Eligible articles were abstracted using a data abstraction tool. Three independent keyword searches on 65 NCCCP plans were conducted. Keyword searches within each of the plans to identify activities related to liver cancer were conducted. Relevant information was abstracted from the plans and saved in a data table.
RESULTS: Of the 20 eligible articles, 15 articles provided information on interventions related to liver cancer and hepatitis B or hepatitis C prevention. All 15 of the intervention articles were related to hepatitis; 13 were hepatitis B-focused, two were hepatitis C-focused, and 14 focused on Asian/Pacific Islander American populations. The independent keyword search of NCCCP plans produced 46 results for liver, 27 results for hepatitis, and 52 results for alcohol. Two plans included activities related to liver cancer. Twenty-four plans included activities related to hepatitis. DISCUSSION: A majority of the intervention articles published focused on HBV infection in Asian/Pacific Islander American populations, and a small percentage of NCCCP plans included liver-related content. The findings from this review will inform the development of an Action Plan on liver cancer prevention for the NCCCP, which will assist programs with the adoption and uptake of promising practices for the prevention of liver cancer.

Entities:  

Keywords:  Carcinoma; Comprehensive cancer control; Health promotion; Hepatocellular; Primary prevention

Mesh:

Year:  2018        PMID: 30506129      PMCID: PMC6685436          DOI: 10.1007/s10552-018-1094-0

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  34 in total

1.  Integrating theory into community interventions to reduce liver cancer disparities: The Health Behavior Framework.

Authors:  Roshan Bastani; Beth A Glenn; Vicky M Taylor; Moon S Chen; Tung T Nguyen; Susan L Stewart; Annette E Maxwell
Journal:  Prev Med       Date:  2009-08-27       Impact factor: 4.018

2.  Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.

Authors:  Cindy M Weinbaum; Ian Williams; Eric E Mast; Susan A Wang; Lyn Finelli; Annemarie Wasley; Stephanie M Neitzel; John W Ward
Journal:  MMWR Recomm Rep       Date:  2008-09-19

3.  What made a successful hepatitis B program for reducing liver cancer disparities: an examination of baseline characteristics and educational intervention, infection status, and missing responses of at-risk Asian Americans.

Authors:  Chiehwen Ed Hsu; Guangyu Zhang; Fang Alice Yan; Ning Shang; Tuan Le
Journal:  J Community Health       Date:  2010-06

4.  The Jade Ribbon Campaign: a model program for community outreach and education to prevent liver cancer in Asian Americans.

Authors:  Stephanie D Chao; Ellen T Chang; Phuoc V Le; Wijan Prapong; Michaela Kiernan; Samuel K S So
Journal:  J Immigr Minor Health       Date:  2007-11-08

5.  3 For Life: a model pilot program to prevent hepatitis B virus infection and liver cancer in Asian and Pacific Islander Americans.

Authors:  Ellen T Chang; Eric Sue; Janet Zola; Samuel K So
Journal:  Am J Health Promot       Date:  2009 Jan-Feb

6.  Reducing liver cancer disparities: a community-based hepatitis-B prevention program for Asian-American communities.

Authors:  Chiehwen Ed Hsu; Louis Chih-Hung Liu; Hee-Soon Juon; Yu-Wen Chiu; Julie Bawa; Ulder Tillman; Mark Li; Jerry Miller; MinQi Wang
Journal:  J Natl Med Assoc       Date:  2007-08       Impact factor: 1.798

7.  Public health model for prevention of liver cancer among Asian Americans.

Authors:  Hee-Soon Juon; Carol Strong; Thomas H Oh; Theresa Castillo; Grace Tsai; Leslie D Hsu Oh
Journal:  J Community Health       Date:  2008-08

8.  Evaluation of a hepatitis B lay health worker intervention for Chinese Americans and Canadians.

Authors:  Vicky M Taylor; T Gregory Hislop; Shin-Ping Tu; Chong Teh; Elizabeth Acorda; Mei-Po Yip; Erica Woodall; Yutaka Yasui
Journal:  J Community Health       Date:  2009-06

9.  Culturally sensitive strategies designed to target the silent epidemic of hepatitis B in a Filipino community.

Authors:  Michelle Marineau; Alan D Tice; David Taylor-Garcia; Kenneth T Akinaka; Heather Lusk; Fernando Ona
Journal:  Hawaii Med J       Date:  2007-06

10.  National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003.

Authors:  Faruque Ahmed; Joseph F Perz; Sandy Kwong; Patricia M Jamison; Carol Friedman; Beth P Bell
Journal:  Prev Chronic Dis       Date:  2008-06-15       Impact factor: 2.830

View more
  8 in total

1.  Promising Interventions to Prevent Liver Cancer in Idaho.

Authors:  Behnoosh Momin; Danielle Nielsen; Spencer Schaff; Jennifer L Mezzo; Charlene Cariou
Journal:  Health Promot Pract       Date:  2021-12-07

Review 2.  Integrated stress response in hepatitis C promotes Nrf2-related chaperone-mediated autophagy: A novel mechanism for host-microbe survival and HCC development in liver cirrhosis.

Authors:  Srikanta Dash; Yucel Aydin; Tong Wu
Journal:  Semin Cell Dev Biol       Date:  2019-08-08       Impact factor: 7.727

3.  Study on clinical application of susceptibility weighted imaging ombined with diffusion weighted imaging in patients with Liver Cirrhosis complicated with small Hepatocellular Carcinoma.

Authors:  Zhi-Bo Hou; Fei Zhao; Bin Zhang; Chun-Zhu Zhang
Journal:  Pak J Med Sci       Date:  2021 May-Jun       Impact factor: 1.088

4.  Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990-2019.

Authors:  Seyyed-Hadi Ghamari; Moein Yoosefi; Mohsen Abbasi-Kangevari; Mohammad-Reza Malekpour; Sahar Saeedi Moghaddam; Sarvenaz Shahin; Zahra Esfahani; Sogol Koolaji; Parnian Shobeiri; Aydin Ghaffari; Hanye Sohrabi; Ameneh Kazemi; Negar Rezaei; Bagher Larijani; Farshad Farzadfar
Journal:  Hepatol Commun       Date:  2022-02-08

5.  Analysis of Clinical Characteristics of Hepatitis B and Alcohol-Related Liver Cancer.

Authors:  Yuefei Pan; Guiliang Han
Journal:  Comput Math Methods Med       Date:  2021-11-18       Impact factor: 2.238

6.  Notoamide-type alkaloid induced apoptosis and autophagy via a P38/JNK signaling pathway in hepatocellular carcinoma cells.

Authors:  Likun Hu; Ting Zhang; Dong Liu; Guiwen Guan; Jian Huang; Peter Proksch; Xiangmei Chen; Wenhan Lin
Journal:  RSC Adv       Date:  2019-06-25       Impact factor: 4.036

7.  Inhibiting roles of FOXA2 in liver cancer cell migration and invasion by transcriptionally suppressing microRNA-103a-3p and activating the GREM2/LATS2/YAP axis.

Authors:  Guangzhen Ma; Jirong Chen; Tiantian Wei; Jia Wang; Wenshan Chen
Journal:  Cytotechnology       Date:  2021-05-26       Impact factor: 2.040

Review 8.  Implementation of Cancer Plans in the United States: A Review.

Authors:  Michael W Bacchus; Bobbie McKee; Clement K Gwede; Christopher R Cogle
Journal:  Healthcare (Basel)       Date:  2021-03-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.